Tessera Therapeutics
Shrey Thaker is a Senior Research Associate at Tessera Therapeutics, with a background in downstream process development and optimization of recombinant vaccines. They have experience in aseptic handling of viral genomes, chromatography, UF/DF, and tech transfer operations. Prior to their current role, they have worked in various companies such as Solid Biosciences, Sanofi Pasteur, and Lupin Pharmaceuticals, where they focused on process engineering, plant operations, and drug formulation. Shrey has a Master of Science in Biomedical/Medical Engineering from the University at Buffalo and a Bachelor of Engineering in Chemical Engineering from the University of Mumbai.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.